BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18205889)

  • 1. Gene-gene interaction between FGF20 and MAOB in Parkinson disease.
    Gao X; Scott WK; Wang G; Mayhew G; Li YJ; Vance JM; Martin ER
    Ann Hum Genet; 2008 Mar; 72(Pt 2):157-62. PubMed ID: 18205889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.
    Satake W; Mizuta I; Suzuki S; Nakabayashi Y; Ito C; Watanabe M; Takeda A; Hasegawa K; Sakoda S; Yamamoto M; Hattori N; Murata M; Toda T
    Neuroreport; 2007 Jun; 18(9):937-40. PubMed ID: 17515805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.
    Kang SJ; Scott WK; Li YJ; Hauser MA; van der Walt JM; Fujiwara K; Mayhew GM; West SG; Vance JM; Martin ER
    Mov Disord; 2006 Dec; 21(12):2175-80. PubMed ID: 17044053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
    Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
    Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
    Clarimon J; Xiromerisiou G; Eerola J; Gourbali V; Hellström O; Dardiotis E; Peuralinna T; Papadimitriou A; Hadjigeorgiou GM; Tienari PJ; Singleton AB
    BMC Neurol; 2005 Jun; 5():11. PubMed ID: 15967032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis.
    Sun YX; Wang XH; Xu AH; Zhao JH
    J Neurol Sci; 2014 Oct; 345(1-2):97-105. PubMed ID: 25066260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.
    Zhu R; Zhu Y; Liu X; He Z
    Neurol Sci; 2014 Dec; 35(12):1889-94. PubMed ID: 24942208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
    Löhle M; Mangone G; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Corvol JC; Storch A
    Mov Disord; 2018 Sep; 33(9):1496-1501. PubMed ID: 30216543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
    Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
    Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
    Quan W; Li J; Liu L; Zhang Q; Qin Y; Pei X; Chen J
    Neurol Sci; 2022 May; 43(5):3145-3152. PubMed ID: 34845561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
    Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
    Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis.
    Ma ZG; Xu J; Liu TW
    Neurol Sci; 2015 Jan; 36(1):47-51. PubMed ID: 25030126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y; Piao X; Wu J; Li Y; Liang Q
    Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
    Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.
    Hotamisligil GS; Girmen AS; Fink JS; Tivol E; Shalish C; Trofatter J; Baenziger J; Diamond S; Markham C; Sullivan J
    Mov Disord; 1994 May; 9(3):305-10. PubMed ID: 7913737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
    van der Walt JM; Noureddine MA; Kittappa R; Hauser MA; Scott WK; McKay R; Zhang F; Stajich JM; Fujiwara K; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
    Am J Hum Genet; 2004 Jun; 74(6):1121-7. PubMed ID: 15122513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ε4 Allele in Alzheimer's Disease.
    Babić Leko M; Nikolac Perković M; Nedić Erjavec G; Klepac N; Švob Štrac D; Borovečki F; Pivac N; Hof PR; Šimić G
    Curr Alzheimer Res; 2021; 18(7):585-594. PubMed ID: 34533445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
    Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
    McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
    Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of the functional MAOA gene promoter and MAOB gene intron 13 polymorphisms in tension type headache patients.
    Edgnülü TG; Özge A; Erdal N; Kuru O; Erdal ME
    Adv Clin Exp Med; 2014; 23(6):901-6. PubMed ID: 25618115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.